Trial Profile
Lipolytic Effects of GH in Human Subjects in Vivo: Molecular Mechanisms and Temporal Patterns
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Somatropin (Primary) ; Pegvisomant
- Indications Growth disorders; Somatotropin deficiency; Turner's syndrome
- Focus Pharmacokinetics
- 01 Apr 2020 Results published in the Metabolism - Clinical and Experimental
- 25 Mar 2020 Status changed from recruiting to completed.
- 12 Nov 2018 New trial record